Trial intelligence / Profile preview

Estetrol with drospirenone or levonorgestrel for contraception (FIESTA)

NCT01221831Phase 2Completed

Sponsor
Estetra SRL
Start
Sep 2010
Primary completion
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of estetrol in contraception (5 arms), sponsored by Estetra SRL. Primary endpoint: Vaginal bleeding patterns. Started Sep 2010; status: completed.

02

Drugs

estetrol
03

Conditions

contraception

Beyond the preview

Go deeper on NCT01221831.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01221831.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call